CENTER FOR NEUROLOGIC STUDY

EIN: 953374771 501(c)(3)

LA JOLLA, CA

Total Revenue
$1,988,290
Total Expenses
$531,222
Total Assets
$27,796,931
Net Assets
$27,796,358
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
1979
Legal Domicile
CA
Principal Officer
RICHARD A SMITH MD
Phone
8584555463
Tax Period
2020-07-01 to 2021-06-30

CENTER FOR NEUROLOGIC STUDY, founded in 1979, is a community nonprofit that reported $2.0M in total revenue in fiscal year 2020. Revenue grew 18% year-over-year, indicating healthy expansion. The organization ran a surplus of $1.5M, a strong 73% operating margin.

Mission

THE CENTER FOR NEUROLOGIC STUDY HAS A STRAIGHTFORWARD MISSION:ADVANCE THE CAUSE OF PATIENTS WITH DISORDERS OF THE NERVOUS SYSTEM. THIS HAS BEEN ACCOMPLISHED THROUGH PROVIDING PATIENT AND FAMILY SUPPORT, DRUG DEVELOPMENT AND CLINICAL RESEARCH.

Program Service Accomplishments

Program 1
Expenses: $325,105

RESEARCH: WORK UNDERTAKEN AT CNS PLAYED A ROLE IN THE INTRODUCTION OF INTERFERON FOR THE TREATMENT OF MULTIPLE SCLEROSIS. THE CENTER PARTICIPATED IN NUMEROUS NATIONAL, EXPERIMENTAL TREATMENT TRIALS...

Read more

RESEARCH: WORK UNDERTAKEN AT CNS PLAYED A ROLE IN THE INTRODUCTION OF INTERFERON FOR THE TREATMENT OF MULTIPLE SCLEROSIS. THE CENTER PARTICIPATED IN NUMEROUS NATIONAL, EXPERIMENTAL TREATMENT TRIALS INVOLVING AMYOTROPHIC LATERAL SCLEROSIS, ALZHEIMER'S DISEASE, NEUROPATHY WHICH LED TO THE DISCOVERY OF NUEDEXTA WHICH HAS BEEN APPROVED FOR USE IN THE UNITED STATES AND EUROPE. REMARKABLY, THE DRUG HAS IMPROVED FUNCTION IN BOTH ALZHEIMER'S DISEASE AND ALS PATIENTS, WITH STUDY RESULTS PUBLISHED IN MAJOR SCIENTIFIC JOURNAlS. PIONEERING WORK DONE AT CNS IN COLLABORATION WITH THE UNIVERSITY OF CALIFORNIA AND IONIS PHARMACEUTICALS IS WIDELY BELIVED TO BE THE MOST PROMISING STRATEGY FOR TREATING NEURODEGENERATIVE DISEASES SUCH AS HUNTINGTON'S DISEASE AND FAMILIAL AMYOTROPHIC LATERAL SCLEROSIS. THIS STRATEGY INVOLVES THE SYNTHESIS OF SMALL MOLECULES THAT DOWN REGULATE THE EXPRESSION OF MUTANT PROTEINS IN THE BRAIN. THE LATTER RESULTS WERE PRESENTED AT THE 2018 ANNUAL MEETING OF THE AMERICAN ACADEMY OF NEUROLOGY.

Program 2

PUBLIC EDUCATION: RESEARCH CONDUCTED AT CNS HAS BEEN PRESENTED PUBLICALLY AT MEDICAL AND SCIENTIFIC MEETINGS AND PUBLISHED IN LEADING SCIENTIFIC JOURNALS. THESE ACTIVITIES HAVE BEEN REPORTED UPON IN...

Read more

PUBLIC EDUCATION: RESEARCH CONDUCTED AT CNS HAS BEEN PRESENTED PUBLICALLY AT MEDICAL AND SCIENTIFIC MEETINGS AND PUBLISHED IN LEADING SCIENTIFIC JOURNALS. THESE ACTIVITIES HAVE BEEN REPORTED UPON IN LOCAL AND NATIONAL MEDIA, INCLUDING NBC AND CNN TELEVISION, THE SAN DIEGO UNION TRIBUNE, THE LOS ANGELES AND NEW YORK TIMES AND SCIENTIFIC AMERICAN. CNS ALSO PROVIDES INFORMATION ABOUT NEUROLOGICAL DISEASES TO PATIENTS, PHYSICIANS AND THE GENERAL PUBLIC VIA IT'S WEBSITE (CNSONLINE.ORG). ADDITIONALY CNS IS INVOLVED IN ORGANIZING AN ANNUAL CONFERENCE ON AMYOTROPHIC LATERAL SCLEROSIS IN COLLABORATION WITH ACADEMIC INSTITUTUIONS IN CALIFORNIA (CALIFORNIA ALS SUMMIT).

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2020)

Revenue Breakdown

Contributions & Grants $44
Program Service Revenue $0
Investment Income $1,938,246
Other Revenue $50,000
TOTAL REVENUE $1,988,290

Expense Breakdown

Grants Paid $75,000
Salaries & Benefits $172,649
Fundraising Expenses $0
Program Expenses $325,105
Other Expenses $283,573
TOTAL EXPENSES $531,222

Year-over-Year Comparison

2020 2019 Change
Revenue $1,988,290 $1,690,290 +0.2%
Expenses $531,222 $971,183 -0.5%
Net Income $1,457,068 $719,107 +1.0%
Key Indicators
✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
6
Independent Members
5
Employees
4
Volunteers
N/A

Governance Policies

✗ Conflict of Interest Policy
✗ Whistleblower Policy
✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School
✗ Operated a Hospital
✗ Provided First Class Travel
⚠ Reported Conflict of Interest
✗ Reported Asset Diversion
✗ Excess Benefit Transaction
✗ Made Political Expenditures
✗ Engaged in Lobbying
✗ Operated Donor Advised Fund
✗ Maintained Art Collections
✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
2
$148,000
Total Directors
7
$148,000
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
RICHARD A SMITH MD President 40.00
Officer Director
$100,000 $0 $100,000
KATHLEEN MYERS SECRETARY/TREAS 8.00
Officer Director
$48,000 $0 $48,000
STEVE BORDNER Director 0.10
Director
$0 $0 $0
DAVID LOUIS CUTCHIN PHD Director 0.10
Director
$0 $0 $0
DARYL SMITH Director 0.10
Director
$0 $0 $0
RANDALL KAYE MD Director 0.10
Director
$0 $0 $0
CHERRYL GOLDSTWIN Director 0.10
Director
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2021 $1,988,290 $531,222 $27,796,931 $1,457,068
2020 $1,690,290 $971,183 $25,215,809 $719,107
2019 $1,385,263 $454,587 $25,452,766 $930,676
2018 $1,027,358 $817,609 $24,408,144 $209,749
Explore More Nonprofits
→Top 100 Nonprofits in California →Largest U.S. Nonprofits →Best Rated Nonprofits →Most Efficient Nonprofits

Compare CENTER FOR NEUROLOGIC STUDY with other nonprofits in California and across the country.

We Value Your Privacy
We use cookies and similar technologies to analyze site traffic and improve your experience. By clicking "Accept All", you consent to our use of cookies for analytics and measurement.